Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW March 2004

Volume 13
Issue Number 3
March 2004
ISSN 10593802

NCCN Recommends Three Strategies for Metastatic Colon and Rectal Cancer

The National Comprehensive Cancer Network (NCCN) Colon Cancer guidelines update recommends three strategies for first-line treatment of metastatic colon and rectal cancer: FOLFOX, FOLFIRI, or bevacizumab combined with 5FU/LV.
Go to Previous Page
Go to Next Page

Source & Additional Reading

P. F. Engstrom, National Comprehensive Cancer Network (NCCN).

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW March 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW March 2004